glp 3 peptide vs glp 1 GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 vs GLP-3 — it's
Description
The inclusion of GLP-1 therapies, such as the active ingredients semaglutide and tirzepatide, applies specifically to people with type 2 diabetes in combination with cardiovascular disease, chronic kidney disease or obesity
Semaglutide causes nausea in a significant percentage of users, particularly during the dose-escalation phase
By being deliberate with every set, I ensure Im challenging myself safely, making progress, and getting stronger with each workout
medRxiv [Preprint] (2020), 2020.09.01.20185850
How to Reduce the Risk Watch for symptoms
This cuts total time to 6 months versus the standard 9 months
